CELEOS

Founded in early 2023 and led by Dr. Philippe Saudemont, CELEOS is a medical technology startup that aims to develop and commercialize a real-time cancer diagnostic device to empower clinicians and improve cancer care.

Theme: Medical technologies

Applications: Diagnostics and biological markers

Laboratory: PRISM

Institutions: University of Lille

Technology

CELEOS provides surgeons with rapid and accurate margin diagnosis and analysis, reducing uncertainty for patients. This revolutionary device uses mass spectrometry and artificial intelligence to compare the molecular signatures of tissue samples taken in vivo with pre-established databases.

Applications

Cancer surgery

Benefits

Coupled with a machine learning algorithm, Celeos provides information on molecular signatures. This new modality will enable clinicians to improve their diagnostic routine by reducing diagnosis time, improving cancer surgery outcomes, and enhancing patients' quality of life.

For more information

Contact your dedicated advisor